Catherine Canales
Catherine Canales is an experienced commercial strategist with over 18 years in business development for life sciences. She has secured global partnerships with both emerging biotechs and leading pharmaceutical companies, helping sponsors align clinical milestones with fundraising and licensing goals. At Astrum, Catherine leads client engagement and strategic growth, ensuring sponsors receive investor-ready results.
Dr. Elisabeth Lackner
Dr. Elisabeth Lackner brings decades of leadership in clinical research and pharma innovation, with a proven track record in scaling international life science operations. As Chair of Astrum’s Board, she provides strategic direction and oversight of corporate governance.
Cristina Lopes
Cristina Lopes has extensive experience in patient recruitment and site management, with a focus on Phase I trials and early patient engagement strategies. She has developed site networks and processes that improved trial efficiency and participant retention across Europe. At Astrum, Cristina leads site and patient services, ensuring trials recruit effectively and deliver meaningful results.
Carlos Faro
Carlos Faro brings more than two decades of financial leadership in the healthcare and clinical research sectors. He has managed budgets for large-scale international operations and driven financial stability during periods of rapid expansion. At Astrum, Carlos oversees financial strategy, ensuring sustainable growth and efficient resourcing for clinical trial delivery.